InsidersTradesSigma
Follow the DISC MEDICINE INC. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was filed on 6 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: RAHUL KHARA. All data is openly available.
Analysts rate DISC MEDICINE INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$101.58.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
DISC Medicine Inc. is a company focused on developing therapies for diseases related to immune dysfunction. It is listed on NASDAQ under the symbol DISC.